756 related articles for article (PubMed ID: 8909915)
1. Impact of the implantable cardioverter-defibrillator on rehospitalizations.
Valenti R; Schlåpfer J; Fromer M; Fischer A; Kappenberger L
Eur Heart J; 1996 Oct; 17(10):1565-71. PubMed ID: 8909915
[TBL] [Abstract][Full Text] [Related]
2. Implantable transvenous cardioverter-defibrillators.
Bardy GH; Hofer B; Johnson G; Kudenchuk PJ; Poole JE; Dolack GL; Gleva M; Mitchell R; Kelso D
Circulation; 1993 Apr; 87(4):1152-68. PubMed ID: 8462144
[TBL] [Abstract][Full Text] [Related]
3. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators.
Bardy GH; Yee R; Jung W
J Am Coll Cardiol; 1996 Aug; 28(2):400-10. PubMed ID: 8800117
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of celivarone, with amiodarone as calibrator, in patients with an implantable cardioverter-defibrillator for prevention of implantable cardioverter-defibrillator interventions or death: the ALPHEE study.
Kowey PR; Crijns HJ; Aliot EM; Capucci A; Kulakowski P; Radzik D; Roy D; Connolly SJ; Hohnloser SH;
Circulation; 2011 Dec; 124(24):2649-60. PubMed ID: 22082672
[TBL] [Abstract][Full Text] [Related]
5. Effectiveness and cost-effectiveness of implantable cardioverter defibrillators in the treatment of ventricular arrhythmias among medicare beneficiaries.
Weiss JP; Saynina O; McDonald KM; McClellan MB; Hlatky MA
Am J Med; 2002 May; 112(7):519-27. PubMed ID: 12015242
[TBL] [Abstract][Full Text] [Related]
6. Implantable cardioverter-defibrillator: present and future indications.
Block M; Scheld H; Breithardt G
Arch Mal Coeur Vaiss; 1996 Feb; 89 Spec No 1():141-7. PubMed ID: 8734176
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
8. Management of sudden cardiac death in cardiac sarcoidosis using the wearable cardioverter defibrillator.
Skowasch D; Ringquist S; Nickenig G; Andrié R
PLoS One; 2018; 13(3):e0194496. PubMed ID: 29566033
[TBL] [Abstract][Full Text] [Related]
9. Cost and length of hospital stay: comparisons between nonthoracotomy and epicardial techniques in patients receiving implantable cardioverter defibrillators.
Luceri RM; Zilo P; Habal SM; David IB
Pacing Clin Electrophysiol; 1995 Jan; 18(1 Pt 2):168-71. PubMed ID: 7724393
[TBL] [Abstract][Full Text] [Related]
10. Is the implantable cardioverter-defibrillator cost-effective?
Lévy S
Eur Heart J; 1996 Oct; 17(10):1458-9. PubMed ID: 8909896
[No Abstract] [Full Text] [Related]
11. Chapter 10. Current evidence on the cost effectiveness of the implantable cardioverter defibrillator.
O'Brien BJ; Yee R
Can J Cardiol; 2000 Jun; 16 Suppl C():45C-7C. PubMed ID: 10887279
[No Abstract] [Full Text] [Related]
12. [The automatic implantable cardioverter-defibrillator for prevention of sudden heart death in children and adolescents].
Paul T; Luhmer I; Trappe HJ; Klein H; Fieguth HG; Brauer C; Scharpwinkel U; Kallfelz HC
Z Kardiol; 1993 Aug; 82(8):466-73. PubMed ID: 8212779
[TBL] [Abstract][Full Text] [Related]
13. Ventricular fibrillation in patients without significant structural heart disease: a multicenter experience with implantable cardioverter-defibrillator therapy.
Meissner MD; Lehmann MH; Steinman RT; Mosteller RD; Akhtar M; Calkins H; Cannom DS; Epstein AE; Fogoros RN; Liem LB
J Am Coll Cardiol; 1993 May; 21(6):1406-12. PubMed ID: 8473649
[TBL] [Abstract][Full Text] [Related]
14. Lessons learned from data logging in a multicenter clinical trial using a late-generation implantable cardioverter-defibrillator. The Guardian ATP 4210 Multicenter Investigators Group.
Wood MA; Stambler BS; Damiano RJ; Greenway P; Ellenbogen KA
J Am Coll Cardiol; 1994 Dec; 24(7):1692-9. PubMed ID: 7963117
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of the implantable cardioverter-defibrillator versus antiarrhythmic drugs in survivors of serious ventricular tachyarrhythmias: results of the Antiarrhythmics Versus Implantable Defibrillators (AVID) economic analysis substudy.
Larsen G; Hallstrom A; McAnulty J; Pinski S; Olarte A; Sullivan S; Brodsky M; Powell J; Marchant C; Jennings C; Akiyama T;
Circulation; 2002 Apr; 105(17):2049-57. PubMed ID: 11980684
[TBL] [Abstract][Full Text] [Related]
16. Effect of clinical risk stratification on cost-effectiveness of the implantable cardioverter-defibrillator: the Canadian implantable defibrillator study.
Sheldon R; O'Brien BJ; Blackhouse G; Goeree R; Mitchell B; Klein G; Roberts RS; Gent M; Connolly SJ
Circulation; 2001 Oct; 104(14):1622-6. PubMed ID: 11581139
[TBL] [Abstract][Full Text] [Related]
17. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
Owens DK; Sanders GD; Heidenreich PA; McDonald KM; Hlatky MA
Am Heart J; 2002 Sep; 144(3):440-8. PubMed ID: 12228780
[TBL] [Abstract][Full Text] [Related]
18. Food for afterthought: reflections from 2 implantable cardioverter defibrillator trials.
Rahimtoola SH
Arch Intern Med; 2004 Sep; 164(17):1835-9. PubMed ID: 15451756
[No Abstract] [Full Text] [Related]
19. [Spanish implantable cardioverter-defibrillator registry. Seventh official report of the spanish society of cardiology working group on implantable cardioverter-defibrillators (2010)].
Alzueta J; Fernández JM
Rev Esp Cardiol; 2011 Nov; 64(11):1023-34. PubMed ID: 21967881
[TBL] [Abstract][Full Text] [Related]
20. Randomized study of implantable defibrillator as first-choice therapy versus conventional strategy in postinfarct sudden death survivors.
Wever EF; Hauer RN; van Capelle FL; Tijssen JG; Crijns HJ; Algra A; Wiesfeld AC; Bakker PF; Robles de Medina EO
Circulation; 1995 Apr; 91(8):2195-203. PubMed ID: 7697849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
